180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.
Munro APS. et al, (2025), Lancet Child Adolesc Health, 9, 404 - 412
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis
Trusinska D. et al, (2025), Eclinicalmedicine, 84
Recent advances in the prevention and treatment of respiratory syncytial virus disease.
Sanchez-Martinez A. et al, (2025), J Gen Virol, 106
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus.
Villaverde S. et al, (2025), Pediatr Infect Dis J, 44, 239 - 245
Maternal views on RSV vaccination during the first season of implementation in England and Scotland.
Williams TC. et al, (2025), Lancet Infect Dis, 25, e135 - e136
The Epidemiology and Clinical Burdens of Human Parainfluenza Virus Infections Amongst Hospitalized Children Under 5 Years of Age in Jordan: A National Multi-Center Cross-Sectional Study
Abu-Helalah M. et al, (2025), Viruses, 17, 170 - 170
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
HAYNES R. et al, (2025), EClinicalMedicine
Communicating about paediatric infectious diseases at the beginning of the 20th century.
Mammas IN. et al, (2025), Med Int (Lond), 5
The recent landscape of RSV vaccine research.
Kelleher K. et al, (2025), Ther Adv Vaccines Immunother, 13
The Epidemiology and Health Burdens of Influenza Infections Amongst Hospitalized Children Under 5 Years of Age in Jordan: A National Multi-Center Cross-Sectional Study.
Abu-Helalah M. et al, (2024), Vaccines (Basel), 13
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
Kristensen M. et al, (2024), Cell Rep Med, 5
The Epidemiology, Clinical, and Economic Burdens of Respiratory Syncytial Virus Infections Amongst Hospitalized Children Under 5 Years of Age in Jordan: A National Multi-Center Cross-Sectional Study
Abu-Helalah M. et al, (2024), Viruses, 16, 1867 - 1867
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Wiseman DJ. et al, (2024), Am J Respir Crit Care Med, 210, 994 - 1001
Prevention of respiratory syncytial virus disease by immunisation.
Benzaken TR. et al, (2024), Archives of disease in childhood. Education and practice edition
What have we learned from animal studies of immune responses to respiratory syncytial virus infection?
Drysdale SB. et al, (2024), J Clin Virol, 175
Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study.
Lees EA. et al, (2024), Pediatr Infect Dis J, 43, 841 - 850
Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis.
Sanchez Clemente N. et al, (2024), Lancet Glob Health, 12, e572 - e588
Nirsevimab for Prevention of RSV Hospitalizations in Infants. Reply.
Faust SN. et al, (2024), N Engl J Med, 390, 1152 - 1153
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus.
Lin G-L. et al, (2024), Nat Commun, 15
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants.
Johnson M. et al, (2024), J Infect Dis, 229, S112 - S119